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Abstract: To date very few studies with small sample size have
compared peroral esophageal myotomy (POEM) with the current
surgical standard of care, laparoscopic Heller myotomy (LHM), in
terms of efficacy and safety, and no recommendations have been
proposed.
To investigate the efficacy and safety of POEM compared with
LHM, for the treatment of achalasia.
The databases of Pubmed, Medline, Cochrane, and Ovid were
systematically searched between January 1, 2005 and January 31,
2015, with the medical subject headings (MeSH) and keywords ‘‘acha-
lasia,’’ ‘‘POEM,’’ ‘‘per oral endoscopic myotomy,’’ and ‘‘peroral
endoscopic myotomy,’’ ‘‘laparoscopic Heller myotomy’’ (LHM),
‘‘Heller myotomy.’’
All types of study designs including adult patients with diagnosis of
achalasia were selected. Studies that did not report the comparison
between endoscopic and surgical treatment, experimental studies in
animal models, single case reports, technical reports, reviews, abstracts,
and editorials were excluded.
The total number of included patients was 486 (196 in POEM group
and 290 in LHM group).aroni, MD, Natale D,
nd Alberto Patriti, MD, PhD
postoperative pain scores (MD¼1.86, 95% CI: 5.17 to 1.44,
P¼ 0.268), analgesic requirements (MD¼0.74, 95% CI: 2.65 to
1.16, P¼ 0.445), and complications (OR¼ 1.11, 95% CI: 0.5–2.44,
P¼ 0.796). Length of hospital stay was significantly lower for POEM
(MD¼0.629, 95% CI: 1.256 to 0.002, P¼ 0.049). There was a
trend toward significant reduction in symptomatic gastroesophageal
reflux rate in favors of LHM compared to POEM group (OR¼ 1.81,
95% CI: 1.11–2.95, P¼ 0.017).
All included studied were not randomized. Furthermore all selected
studies did not report the results of follow-up longer than 1 year and
most of them included patients who were both treatment naive and
underwent previous endoscopic or surgical interventions for achalasia.
POEM represents a safe and efficacy procedure comparable to the
safety profile of LHM for achalasia at a short-term follow-up. Long-
term clinical trials are urgently needed.
(Medicine 95(10):e3001)
Abbreviations: ACROBAT-NRSI = A Cochrane risk of bias
assessment tool for nonrandomized studies of interventions, CI =
confidence interval, EGJ = esophagogastric junction, GER =
gastroesophageal reflux, GERD = Gastroesophageal Reflux
Disease, GerdQ = Gastroesophageal Reflux Disease
Questionnaire, LES = lower esophageal sphincter, LHM =
laparoscopic Heller myotomy, MeSH = medical subject headings,
OR = odds ratio, POEM = peroral esophageal myotomy, PRISMA
= Preferred Reporting Items for Systematic Review and Meta-
analysis, SD = standard deviation.
INTRODUCTION
A chalasia is a disorder of esophageal motility characterizedby an incomplete or absent esophagogastric junction (EGJ)
relaxation associated with loss of peristalsis or uncoordinated
contractions of the esophageal body in response to swallowing.
The subsequent functional EGJ outflow obstruction and inef-
fective food bolus transit result in progressively severe dyspha-
gia for liquids and solids, and can additionally cause nonacid
regurgitation, aspiration, chest pain, weight loss, and eventually
an irreversible dilation of the esophageal body.1–3 All the
current available therapeutic interventions have palliative
intent and seek to abolish the EGJ pressures in order to
facilitate passive transit of food boluses into the stomach
improving the symptoms related to esophageal stasis.4–6
Although over the years pharmacotherapy (calcium channel
antagonists, nitrates) and endoscopic injection of botulinum
toxin have been favored as possible treatment modalities, the
current standard of care include either endoscopic pneumaticyotomy (laparoscopic Heller myotomy
J. A recent randomized trial found these
to have similar efficacy in terms of
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symptom relief at 2-year follow-up.5,7 Considerable evidence
exists, however, that LHM provides the most durable symp-
toms improvement8,9 without the need for repeated and
multiple interventions to maintain this effect, contrarily to
what is often necessary with endoscopic pneumatic
dilation.6–8
In 2010, Inoue et al10 introduced the peroral esophageal
myotomy (POEM), a novel procedure for the treatment of
achalasia that combined peculiarities of both endoscopic
dilation (no skin incisions, decreased pain, and less blood
loss) and LHM (durable surgical myotomy and single pro-
cedure). Since then, several single and multicenter institution
POEM case series have demonstrated excellent results in terms
of symptomatic relief and improvement in EGJ physiology at
short-term follow-up, confirming the feasibility of this tech-
nique for the treatment of achalasia.11–13 Nevertheless, very
few studies with small sample size have compared POEM with
the current surgical standard of care, LHM, in terms of efficacy
and safety, and no recommendations have been proposed.
Therefore, a systematic review and meta-analysis was con-
ducted to investigate if there is a significant difference in
efficacy and safety between POEM and LHM for the treatment
of esophageal achalasia in the adult patients.
METHODS
Searches
We planned and performed this systematic review and
meta-analysis in accordance with Preferred Reporting Items
for Systematic Review and Meta-analysis (PRISMA) state-
ment14 and Cochrane Handbook for Systematic Reviews of
Intervention.15 We critically assessed the reporting quality of
the study according to the PRISMA 2009 checklists.16 A
literature search in Pubmed, Medline, Cochrane, and Ovid
databases of all articles published, between January 1, 2005
and January 31, 2015with the medical subject headings (MeSH)
and keywords ‘‘achalasia,’’ ‘‘POEM,’’ ‘‘per oral endoscopic
myotomy,’’ and ‘‘peroral endoscopic myotomy,’’ ‘‘laparoscopic
Heller myotomy,’’ ‘‘Heller myotomy’’ was independently car-
ried out by two investigators. The key words were used in all
possible combinations to obtain the maximal number of articles.
Selection
The articles were then screened for the presence of the
following inclusion criteria: adult patients with diagnosis of
achalasia. All types of study designs were included. Studies that
did not report the comparison between endoscopic (POEM) and
surgical (LHM) treatment, experimental studies in animal
models, single case reports, technical reports, reviews, abstracts,
and editorials were excluded. There were no language restric-
tions in the selection. The bibliography of all selected articles
was hand searched to identify additional articles that met our
inclusion criteria. In cases where multiple publications were
availablewith increasing number of patients or longer follow-up
for the same group, only data from the most recent article were
used for statistical analysis.
Data Extraction
Two of the authors (LM and AP) independently reviewed
the formal published versions of all eligible studies for content
Marano et aland screened them according to the specified inclusion criteria
using a data extraction form based on the Cochrane Con-
sumers and Communication Review Group’s data extraction
2 | www.md-journal.comtemplate.15 Disagreements were resolved by discussion
between the 2 review authors; if no agreement could be
reached, it was planned a third author which would decide.
The following data were recorded: type of study design,
mono- or multicentricity, country of origin, year of publication,
number of patients, median/mean patient age, gender distri-
bution, preoperative Eckardt score, procedural time (in min-
utes), intra- and postoperative complications, postoperative pain
score, postoperative analgesic dose (mg of morphine equiva-
lents), days of hospitalization, follow-up duration (in months),
postoperative Eckardt score and postprocedure symptomatic
gastroesophageal reflux (GER).
The ethical approval was not necessary for this type
of article.
Summary Measures
The primary outcome measure was the mean difference in
reducing Eckardt score comparing POEM to LHM. The mean
difference in procedure time, length of hospital stay, postopera-
tive pain score and analgesic requirement, as well as the odds
ratio (OR) of complications and postprocedure symptomatic
GER comparing POEM to LHM was investigated as a
secondary analysis.
Risk of Bias Assessment
A Cochrane risk of bias assessment tool for nonrando-
mized studies of interventions (ACROBAT-NRSI) was indivi-
dually applied to all selected studies. The risk of bias of each
study was rated as ‘‘critical risk,’’ ‘‘serious risk,’’ ‘‘moderate
risk,’’ ‘‘low risk’’ or ‘‘no information’’ according to the match
level between information extracted and evaluation criteria.15
Statistical Analysis
Effect sizes for numerical variables were expressed as
difference in means with 95% confidence interval (CI); while
that of categorical data were expressed as OR with 95% CI.
Whenever data in individual studies were expressed as a median
and range, they were converted to estimated mean standard
deviation (SD) before analysis using ‘‘Estimation of a sample’s
mean and variance from its median and range software’’
(VassarStats: Website for Statistical Computation, www.vassar-
stats.net, Richard Lowry, Poughkeepsie, NY) on the basis of the
sample’s reported median and range according to the method
devised by Hozo et al.17 A pre–post design was used for
evaluating the outcomes after POEM and LHM in the same
groups. Due to the small numbers of studies, we tested for
heterogeneity between-study with the I2 measure.15 Percen-
tages of around 25% (I2¼ 25), 50% (I2¼ 50), and 75%
(I2¼ 75) were considered at low, moderate, and high hetero-
geneity, respectively. A x2 based Q-test was also performed to
check between-study heterogeneity. When an I value higher
than 50 indicated moderate heterogeneity between the studies
the effect size for each study was calculated by the random-
effect model DerSimonian–Laird approach.15 Alternatively a
fixed-effect model was run. Publication bias was evaluated and
quantified by the Egger test. With regard to outcomes when
significant heterogeneity existed across studies, sensitivity
analysis was performed by sequentially omitting each study
to test the influence of each individual study on pooled data. In
case of overlapped patients between the studies we tried to
Medicine  Volume 95, Number 10, March 2016contact the corresponding authors to obtain the raw data.
Otherwise the patients were excluded from the ultimate
analysis. We did not produce the Funnel plot to test the
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
publication bias due to the limited number (below 10) of studies
included in each analysis.16 All analyses were performed using
Comprehensive Meta-analysis software (Version 3.3.070,
November 21, 2014).
RESULTS
Study Selection and Characteristics
The initial search produced 283 studies, of which 192 were
selected for eligibility assessment after exclusion of duplicates.
After detailed evaluation, 11 studies fulfilled criteria for eligi-
bility. One hundred eighty-one studies that were not related to
the comparison between endoscopic (POEM) and surgical
(LHM) treatment were excluded. Of the remaining 11 records,
7 fulfilled criteria for inclusion in the meta-analysis.18–24
Among the 4 excluded studies, 2 were reviews and 2 were
studies performed in children with esophageal achalasia.
The included retrospective case–control studies concerned
different cohorts of patients published between 2013 and 2015,
except for 2 studies21,24 in which the same group may overlap.
The total number of included patients was 486 (196 in POEM
group and 290 in LHM group) ranging from 8 to 180 patients
per study.Mean (SD) age of the patients was 49.5 (11.8) years in
POEM group and 47.8 (11.8) in LHM group. Among the 7
studies, 6 studies (306 patients, 63%) were performed in the
United States populations, and the remaining 1 study (180
patients, 37%) was multicenter (Germany, Netherlands, Swit-
zerland, and Canada). Perioperative symptom assessment was
similar in 5 studies; in 3 studies20,21,24 high-resolution mano-
metry were performed instead of stationary esophageal mano-
metry and the data were evaluated according to the Chicago
Classification of esophageal motility disorders.25 Previous
interventions were reported for 61 cases that included: endo-
scopic pneumatic dilatation in 14 patients; botulinum injection
in 9, combined botulinum injection with dilatation in 6, surgical
myotomy in 6. Two studies did report the number of patients
who underwent interventions (n¼ 26) but did not mention the
details. Similarly, 2 studies reported the interventions but did
not specify the number of patients. Only 1 study included
patients without prior endoscopic or surgical treatment of
achalasia. As regard the LHM operative technique, a partial
anterior (Dor) or posterior (Toupet) fundoplication was per-
formed after esophagogastric myotomy in all included patients.
In all studies were registered no conversion to the other
procedures or perioperative mortality. Mean (SD) follow-up
resulted in 6.4 (4.6) months. The characteristics of each study
included in the meta-analysis are shown in Table 1.
All 7 studies, 6 full-text articles and 1 brief report, were
retrospective case–control studies due to limitation in surgical
blinding or randomization. Nevertheless the evaluation of each
study followed by the Cochrane risk of bias assessment tool for
nonrandomized studies of interventions (ACROBAT-NRSI)
resulted in ‘‘Moderate risk of bias’’ judgment for all studies.
Quantitative Data Synthesis
Eckardt Score Reduction
Five studies reported available data regarding the
reduction in Eckardt score. The outcome showed no significant
difference between POEM and LHM (MD¼0.659, 95% CI:
1.70 to 0.38, P¼ 0.217) (Figure 1). Significant heterogeneity
Medicine  Volume 95, Number 10, March 2016existed among the included studies (I2¼ 94.3%, P< 0.001),
and a random-effect analysis model was used. Sensitivity
analysis by sequentially omitting each study did not alter the
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.primary outcome. Furthermore 2 studies were from the same
groups,21,24 which led to a possibility of double reporting of
cases. In order to negate this only data from the most recent
article were used for statistical analysis.
Operative Time and Hospital Stay
No significant difference between POEM and LHM was
found regarding the operative time (MD¼0.354, 95% CI:
1.12 to 0.41, P¼ 0.36) (Figure 2). A random-effect analysis
model was run due to significant heterogeneity between studies
(I2¼ 82.1%, P¼ 0.001). The same studies were pooled in the
analysis as regard the length of hospital stay, resulting in a lower
hospital time of POEM compared with LHM (MD¼0.629,
95% CI: 1.256 to 0.002, P¼ 0.049) (Figure 3). Significant
heterogeneity was found among the included studies
(I2¼ 71.8%, P¼ 0.014), and a random-effect analysis model
was used. Sensitivity analysis was repeated sequentially omit-
ting each study without primary outcome alteration.
Postoperative Pain Score and Analgesic Requirement
There was no statistically significant difference in the
reduction of postoperative pain score (MD¼1.86, 95% CI:
5.17 to 1.44, P¼ 0.268) (Figure 4) and analgesic medi-
cation (mg of morphine equivalent) dose (MD¼0.74, 95%
CI: 2.65 to 1.16, P¼ 0.445) (Figure 5) resulting from the
analysis of data of 2 studies. Significant heterogeneity was
found among the included studies regarding the investigated
outcomes (I2¼ 97%, P< 0.001) and (I2¼ 94.3%,
P< 0.001), respectively.
Complications
Four studies reported available data regarding the compli-
cation rate. Bleeding and perioperative perforation were
indexed as major complications, while urinary retention, splenic
capsular injury, atrial fibrillation, vagal nerve injury, and
subcutaneous emphysema were listed as minor complications
according to Clavien–Dindo classification of surgical compli-
cations.26 The results of meta-analysis of overall complications
did not differ between POEM and LHM (OR¼ 1.11, 95% CI:
0.5–2.44, P¼ 0.796) (Figure 6). Similarly, there was no stat-
istically significant difference in the major complication rate as
well as minor complication rate between endoscopic and
laparoscopic technique: (OR¼ 1.33, 95% CI: 0.24–7.35,
P¼ 0.74) and (OR¼ 1.82, 95% CI: 0.48–6.9, P¼ 0.375),
respectively (data not shown). The test for heterogeneity was
not significant (I2¼ 0%, P¼ 0.482).
Postprocedure Symptomatic Gastroesophageal
Reflux
Five studies reported the incidence of postprocedure symp-
tomatic gastroesophageal reflux, which was estimated by a
Gastroesophageal Reflux Disease Questionnaire (GerdQ) score
727 or a DeMeester score of 14.7% at pH testing. In the
report by Bhayani et al18 the 24-hour testing of esophageal acid
exposure was obtained only in 23 (76%) POEM and 31 (48%)
LHM patients. The fixed effect analysis model was used
because of low heterogeneity (I2¼ 0%, P¼ 0.651). There
was a trend toward significant reduction in symptomatic gastro-
esophageal reflux rate in favor of LHM compared to POEM
POEM Versus Surgery for Achalasiagroup (OR¼ 1.81, 95% CI: 1.11–2.95, P¼ 0.017) (Figure 7).
Furthermore sensitivity analysis was rerun sequentially omit-
ting each study without primary outcome alteration.
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FIGURE 1. Forrest plot showing comparison of the efficacy of POEM with LHM in reducing Eckardt score.
FIGURE 2. Forrest plot showing comparison of operative time required for POEM with that for LHM.
FIGURE 3. Forrest plot showing comparison of the length of hospital stay after POEM with that after LHM.
FIGURE 4. Forrest plot showing comparison of postoperative pain score after POEM with that after LHM.
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FIGURE 5. Forrest plot showing comparison of postoperative analgesic requirement after POEM with that after LHM.
r P
Marano et al Medicine  Volume 95, Number 10, March 2016DISCUSSION
In the present systematic review and meta-analysis, we
demonstrate that: POEM and LHM are similar in terms of
Eckardt score reduction, complications, postoperative analgesic
need, operative time and length of hospital stay; POEM shows
worse short-term results compared to LHM as regard the
postprocedure symptomatic GER development.
Although the etiology of esophageal achalasia is scarcely
understood, there is common consensus on its treatment, directed
to reducing lower esophageal sphincter (LES) pressure in order to
obtain symptoms relief, improve the esophageal emptying and
FIGURE 6. Forrest plot showing comparison of complications afteprevent the development of megaesophagus.28 Among the var-
ious treatmentmodalities like pharmacotherapy (calciumchannel
antagonists, nitrates),28,29 endoscopic pneumatic dilatation30,31
FIGURE 7. Forrest plot showing comparison of symptomatic gastroe
6 | www.md-journal.comand injection of botulinum toxin,32,33 the surgical esophagogas-
tric extramucosal myotomy with partial fundoplication fulfilled
the best short- and long-term clinical outcomes, especially with
minimally invasive approach, and now is considered the treat-
ment of choice for achalasic patients.5,7,8 Furthermore, in the last
few years, there has been an impetus in the direction of a more
minimal approach to achalasia and in 2010 Inoue et al10 intro-
duced the Per-Oral Esophageal Myotomy as a promising endo-
scopic minimally invasive technique with overall initial good
patient satisfaction and relief of dysphagia. Since then, many
institutions started to investigate the feasibility, safety, and
OEM with that after LHM.efficacy of this innovative endoscopic procedure with encoura-
ging results.11–13 More recently, Inoue et al34 published the
largest single center cohort study on 500 consecutive achalasic
sophageal reflux after POEM with that after LHM.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
patients treated with POEM, reporting the longest follow-up of
POEM patients registered to date (3 years). Based on this large
series, POEM resulted in significant improvements in Eckardt
scores and LES pressures at postoperative short- as well long-
term follow up with no mortality rate and rare adverse events
(3.2%), highlighting the safety and effectiveness of this treatment
as first- or second-line therapy for achalasia.33
Nevertheless, very few studies with small sample size have
compared POEM with the current surgical standard of care,
LHM, and no recommendations have been proposed.
The current meta-analysis involved 7 studies compared
POEM with Heller myotomy in a nonrandomized manner with
486 included patients (196 in POEM group and 290 in LHM
group) ranging from 8 to 180 patients per study. Seven studies
were all judged as ‘‘moderate risk of bias’’ according to
Cochrane risk of bias assessment tool for nonrandomized
studies of interventions (ACROBAT-NRSI).
The efficacy in reduction of Eckardt score was the primary
outcome measure of this study. In terms of symptomatic
efficacy, the Eckardt score (maximum score, 12) is the sum
of the symptom scores for dysphagia, regurgitation, chest pain
(0, absent; 1, occasional; 2, daily; and 3, each meal), and weight
loss (0, no weight loss; 1, <5 kg; 2, 5–10 kg; and 3, >10 kg),
representing a validated and comprehensive assessment of
disease severity.34 Even though the limitations of small num-
bers and short-term follow-up, POEM resulted in a success rate
of 90%, similar to initial treatment success of LHM.8,11 Further-
more in this present meta-analysis, we found a comparable
decrease in Eckardt score between groups.
There was no significant difference between POEM and
LHM as regard the time of interventions, postoperative pain
score, and analgesic requirement. Indeed, length of hospital stay
was significantly less in POEM compared to LHM.
Previous studies were also investigated as regard
postoperative complications.
Swanstrom et al11 reported a 16.7% esophageal perforation
during POEM in their preliminary experience, and Von Renteln
et al22 described an high intraoperative complication rate (69%
full-thickness dissection in the mediastinum and 57% perfor-
ation into the peritoneal cavity). On the other hand some case
series of small sample size determined no serious POEM-
related complications13,35 and, more recently, Inoue et al34
reported an adverse event rate of 3.2% in a large case series
on 500 patients. Even if the total number of adverse events
appeared to be higher than what would usually be seen with
other treatments, most of these were inherent to POEM and
were self-limiting. Majority of the symptomatic adverse events
could be managed conservatively and no perioperative
mortality or conversion to the other procedure was found in
any study. Furthermore the frequency of perforation and bleed-
ing was not high and the results of meta-analysis of overall
complications as well as major and minor adverse events did not
differ between POEM and LHM, emerging POEM as a safe
procedure that was comparable to the safety profile of LHM. Of
course, POEM represents a challenging procedure that should
be performed only in specialized centers by experts in inter-
ventional endoscopy or surgeons with advanced skills in endo-
scopy, to guarantee the highest outcomes for the patients.
POEM operators must be expert in esophageal pathology,
particularly as regard the EGJ peculiarities, the submucosal
dissection technique and the management of the most frequent
Medicine  Volume 95, Number 10, March 2016complications.36 To this address a learning curve of approxi-
mately 20 cases has been proposed to achieve the learning curve
plateau in POEM for an experienced endoscopist.37
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.Nevertheless, gastroesophageal reflux is a common
dilemma after a transoral approach for myotomy since no
antireflux procedure is involved differently from surgical myot-
omy. To this address, many authors showed very good out-
comes with the application of an antireflux procedure to
laparoscopic or laparotomic myotomy, reporting an incidence
of pathological gastroesophageal reflux of 5.7% to 10%.38–42
Furthermore, a prospective randomized trial performed by
Richards et al43 evidenced pathological GER rate of 47.6%
in the group with Heller myotomy without antireflux procedure
compared with a 9.1% in the group with Heller myotomy
followed by anterior fundoplication, with no statistical signifi-
cant differences between the 2 groups as regard postoperative
dysphagia score. Indeed, last retrospective studies evaluating
the long-term outcomes of LHM demonstrated a pathological
GER rate of 11.3% to 80%,44–46 while a more recent meta-
analysis showed that an antireflux procedure following myot-
omy is associated with a lower pathologic acid exposure and
GER, and that the dysphagia relief is not affected by the type of
fundoplication.8,42,43
On the other hand, endoscopic myotomy through the lumi-
nal side accounts for an incidence between 0% and 37% of
symptomatic GER after POEM during short-term follow-
up.13,47–51 Interestingly, Inoue et al34 reported endoscopic find-
ings of reflux esophagitis in 64.7% andGERD symptoms, such as
heartburn or regurgitation, in 16.8% of patients at 2 months post-
POEM follow-up; at 1 to 2 years after POEM, GERD symptoms
were registered in 19.4% of patients and endoscopic evidence of
esophagitis was noted in 59.2% of patients. Similarly, at 3 years
follow-up, similar results were found, accounting the GERD
symptoms for 21.3% of patients and endoscopic evidence of
esophagitis for 56.3% of patients. However, in all cases reflux
symptoms were completely controlled by proton pump inhibitors
therapy.34 Although this large single center cohort study is the
first to report 3 years outcomes regarding gastroesophageal
reflux, some limitations, such as inclusion of relatively small
number of greater curvature POEMs as well as significant long-
term missing data rate, make challenging to deduce any solid
conclusions about this debated issue.
Overall, our pooled outcomes on postprocedure sympto-
matic gastroesophageal reflux showed a trend toward signifi-
cant reduction in favor of LHM compared to POEM group
(OR¼ 1.81, 95% CI: 1.11–2.95, P¼ 0.017). Nevertheless,
future studies are needed to investigate the long-term effects
of POEM on acid reflux.
Our study was affected by some limitations. High hetero-
geneity rate, no randomization of patients and significant pub-
lication bias certainly constituted the weak points of the seven
included studies. Furthermore all selected studies did not report
the results of follow-up longer than 1 year and most of them
included patients who were both treatment naive and underwent
previous endoscopic or surgical interventions for achalasia.
This meta-analysis points to the urgent need of high quality
clinical trials with long-term evaluation comparing POEM with
other standard procedures, including surgical myotomy, in a
randomized manner.
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